Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 212964, 11 pages
http://dx.doi.org/10.1155/2015/212964
Clinical Study

Serum Oxidative Stress Markers and Genotoxic Profile Induced by Chemotherapy in Patients with Breast Cancer: A Pilot Study

1Laboratory of Genetic Toxicity, Postgraduate Program in Pharmaceutical Sciences, Federal University of Piauí, 64049-550 Teresina, PI, Brazil
2Postgraduate Program in Genetics, State University of São Paulo, 14049-900 Ribeirão Preto, SP, Brazil
3Laboratory of Experimental Cancerology, Department of Biophysics and Physiology, Postgraduate Program in Pharmaceutical Sciences, Federal University of Piauí, 64049-550 Teresina, PI, Brazil
4Chemistry Department, University of Alabama in Huntsville, Huntsville, AL 35899, USA
5Laboratory of Research in Experimental Neurochemistry, Postgraduate Program in Pharmaceutical Sciences, Federal University of Piauí, 64049-550 Teresina, PI, Brazil

Received 29 November 2014; Revised 2 March 2015; Accepted 2 March 2015

Academic Editor: Amit Tyagi

Copyright © 2015 Antonio Luiz Gomes Júnior et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Kumaraguruparan, J. Kabalimoorthy, and S. Nagini, “Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast,” Clinical Biochemistry, vol. 38, no. 2, pp. 154–158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Tsai, M. F. Hou, S. H. Wu et al., “Expression of manganese superoxide dismutase in patients with breast cancer,” Kaohsiung Journal of Medical Sciences, vol. 27, pp. 167–172, 2011. View at Publisher · View at Google Scholar
  3. A. Gönenç, D. Erten, S. Aslan, M. Akinci, B. Şimşek, and M. Torun, “Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease,” Cell Biology International, vol. 30, no. 4, pp. 376–380, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. H. Agnoletto, T. N. Guecheva, F. Dondé et al., “Association of low repair efficiency with high hormone receptors expression and SOD activity in breast cancer patients,” Clinical Biochemistry, vol. 40, no. 16-17, pp. 1252–1258, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. A. Amin, B. M. Mohamed, M. A. M. El-Wakil, and S. O. Ibrahem, “Impact of breast cancer and combination chemotherapy on oxidative stress, hepatic and cardiac markers,” Journal of Breast Cancer, vol. 15, no. 3, pp. 306–312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Sánchez-Suárez, P. Ostrosky-Wegman, F. Gallegos-Hernández et al., “DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 640, no. 1-2, pp. 8–15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. P. M. de Almeida, M. G. R. de Gutiérrez, and N. P. Adami, “Monitoramento e avaliação dos efeitos colaterais da quimioterapia em pacientes com câncer de cólon,” Revista Latino-Americana de Enfermagem, vol. 12, no. 5, pp. 760–766, 2004. View at Publisher · View at Google Scholar
  8. C. M. Walko and C. Grande, “Management of common adverse events in patients treated with Sorafenib: nurse and pharmacist perspective,” Seminars in Oncology, vol. 41, supplement 2, pp. S17–S28, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Vaghef, P. Nygren, C. Edling, J. Bergh, and B. Hellman, “Alkaline single-cell gel electrophoresis and human biomonitoring for genotoxicity: a pilot study on breast cancer patients undergoing chemotherapy including cyclophosphamide,” Mutation Research—Genetic Toxicology and Environmental Mutagenesis, vol. 395, no. 2-3, pp. 127–138, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Marsh and G. Liu, “Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy,” Advanced Drug Delivery Reviews, vol. 61, pp. 381–387, 2009. View at Publisher · View at Google Scholar
  11. J. Sastre-Serra, A. Valle, M. M. Company, I. Garau, J. Oliver, and P. Roca, “Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer,” Free Radical Biology and Medicine, vol. 48, no. 4, pp. 506–512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Vera-Ramirez, P. Sanchez-Rovira, M. C. Ramirez-Tortosa et al., “Does chemotherapy-induced oxidative stress improve the survival rates of breast cancer patients?” Antioxidants and Redox Signaling, vol. 15, no. 4, pp. 903–909, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. L. R. Freeman and J. N. Keller, “Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1822, no. 5, pp. 822–829, 2012. View at Publisher · View at Google Scholar
  14. H. Rodriguez-Rocha, A. Garcia-Garcia, M. I. Panayiotidis, and R. Franco, “DNA damage and autophagy,” Mutation Research, vol. 711, no. 1-2, pp. 158–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Vijg, “Somatic mutations and aging: a re-evaluation,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 447, no. 1, pp. 117–135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Badjatia, A. Satyam, P. Singh, A. Seth, and A. Sharma, “Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma,” Urologic Oncolog, vol. 28, no. 4, pp. 360–367, 2010. View at Publisher · View at Google Scholar
  17. C. Glorieux, N. Dejeans, B. Sid, R. Beck, P. B. Calderon, and J. Verrax, “Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy,” Biochemical Pharmacology, vol. 82, no. 10, pp. 1384–1390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Gönenç, A. Hacişevki, S. Aslan, M. Torun, and B. Şimşek, “Increased oxidative DNA damage and impaired antioxidant defense system in patients with gastrointestinal cancer,” European Journal of Internal Medicine, vol. 23, no. 4, pp. 350–354, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. V. Carrano and A. T. Natarajan, “Considerations for population monitoring using cytogenetic techniques International Comission for protection against Environmental Mutagens and Carcinogens (ICPEMC publication 14),” Mutation Research, vol. 204, no. 3, pp. 379–406, 1988. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Hoffmann, J. Högel, and G. Speit, “The effect of smoking on DNA effects in the comet assay: a meta-analysis,” Mutagenesis, vol. 20, no. 6, pp. 455–466, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. N. P. Singh, M. T. McCoy, R. R. Tice, and E. L. Schneider, “A simple technique for quantitation of low levels of DNA damage in individual cells,” Experimental Cell Research, vol. 175, no. 1, pp. 184–191, 1988. View at Publisher · View at Google Scholar · View at Scopus
  22. R. R. Tice, E. Agurell, D. Anderson et al., “Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing,” Environmental and Molecular Mutagenesis, vol. 35, no. 3, pp. 206–221, 2000. View at Publisher · View at Google Scholar
  23. O. García, T. Mandina, A. I. Lamadrid et al., “Sensitivity and variability of visual scoring in the comet assay: results of an inter-laboratory scoring exercise with the use of silver staining,” Mutation Research, vol. 556, no. 1-2, pp. 25–34, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. R. Collins, “The comet assay for DNA damage and repair: principles, applications, and limitations,” Applied Biochemistry and Biotechnology, Part B Molecular Biotechnology, vol. 26, no. 3, pp. 249–261, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Dusinska and A. R. Collins, “The comet assay in human biomonitoring: gene-environment interactions,” Mutagenesis, vol. 23, no. 3, pp. 191–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. L. C. Green, S. R. Tannenbaum, and P. Goldman, “Nitrate synthesis in the germfree and conventional rat,” Science, vol. 212, no. 4490, pp. 56–58, 1981. View at Publisher · View at Google Scholar · View at Scopus
  27. E. D. Wills, “Mechanisms of lipid peroxide formation in animal tissues,” Biochemical Journal, vol. 99, no. 3, pp. 667–676, 1966. View at Google Scholar · View at Scopus
  28. H. H. Draper and M. Hadley, “Malondialdehyde determination as an index of lipid peroxidation,” in Methods in Enzymology, vol. 186, pp. 421–431, 1990. View at Publisher · View at Google Scholar
  29. J. Sedlak and R. H. Lindsay, “Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent,” Analytical Biochemistry, vol. 25, no. 1, pp. 192–205, 1968. View at Publisher · View at Google Scholar
  30. D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967. View at Google Scholar · View at Scopus
  31. B. Chance and A. C. Maehly, “Assay catalases and peroxidases,” Methods in Enzymology, vol. 2, pp. 764–768, 1995. View at Google Scholar
  32. J. R. Arthur and R. Boyne, “Superoxide dismutase and glutathione peroxidase activities in neutrophils from selenium deficient and copper deficient cattle,” Life Sciences, vol. 36, no. 16, pp. 1569–1575, 1985. View at Publisher · View at Google Scholar · View at Scopus
  33. S. T. Miorelli, R. M. Rosa, D. J. Moura et al., “Antioxidant and anti-mutagenic effects of ebselen in yeast and in cultured mammalian V79 cells,” Mutagenesis, vol. 23, no. 2, pp. 93–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. E. A. Rakha, J. S. Reis-Filho, F. Baehner et al., “Breast cancer prognostic classification in the molecular era: the role of histological grade,” Breast Cancer Research, vol. 12, pp. 1–12, 2010. View at Publisher · View at Google Scholar
  35. D. Pande, R. Negi, S. Khanna, R. Khanna, and H. D. Khanna, “Vascular endothelial growth factor levels in relation to oxidative damage and antioxidant status in patients with breast cancer,” Journal of Breast Cancer, vol. 14, no. 3, pp. 181–184, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. S. J. Ralph, S. Rodríguez-Enríquez, J. Neuzil, E. Saavedra, and R. Moreno-Sánchez, “The causes of cancer revisited: ‘Mitochondrial malignancy’ and ROS-induced oncogenic transformation—why mitochondria are targets for cancer therapy,” Molecular Aspects of Medicine, vol. 31, no. 2, pp. 145–170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Rockenbach, P. F. di Pietro, C. Ambrosi et al., “Dietary intake and oxidative stress in breast cancer: before and after treatments,” Nutricion Hospitalaria, vol. 26, no. 4, pp. 737–744, 2011. View at Google Scholar · View at Scopus
  38. C. G. Vallejo, A. Cruz-Bermúdez, P. Clemente, R. Hernández-Sierra, R. Garesse, and M. Quintanilla, “Evaluation of mitochondrial function and metabolic reprogramming during tumor progression in a cell model of skin carcinogenesis,” Biochimie, vol. 95, no. 6, pp. 1171–1176, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Gupta, B. Goswami, and P. Mittal, “Effect of standard anthracycline based neoadjuvant chemotherapy on circulating levels of serum IL-6 in patients of locally advanced carcinoma breast—a prospective study,” International Journal of Surgery, vol. 10, no. 10, pp. 638–640, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. T. T. Reed, “Lipid peroxidation and neurodegenerative disease,” Free Radical Biology and Medicine, vol. 51, no. 7, pp. 1302–1319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Panis, A. C. S. A. Herrera, V. J. Victorino et al., “Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy,” Breast Cancer Research and Treatment, vol. 133, no. 1, pp. 89–97, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Alagöl, E. Erdem, B. Sancak, G. Turkmen, M. Camlibel, and G. Bugdayci, “Nitric oxide biosynthesis and malondialdehyde levels in advanced breast cancer,” Australian and New Zealand Journal of Surgery, vol. 69, no. 9, pp. 647–650, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Pastore, G. Federici, E. Bertini, and F. Piemonte, “Analysis of glutathione: implication in redox and detoxification,” Clinica Chimica Acta, vol. 333, no. 1, pp. 19–39, 2003. View at Google Scholar
  44. S. Aggarwal, M. Subberwal, S. Kumar, and M. Sharma, “Brain tumor and role of β-carotene, α- tocopherol, superoxide dismutase and glutathione peroxidase,” Journal of Cancer Research and Therapeutics, vol. 2, no. 1, pp. 24–27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Subramaniam, S. Subramaniam, and C. S. Shyamala Devi, “Erythrocyte antioxidant enzyme activity in CMF treated breast cancer patients,” Cancer Biochemistry Biophysics, vol. 14, no. 3, pp. 177–182, 1994. View at Google Scholar · View at Scopus
  46. G. Singh, S. K. Maulik, A. Jaiswal, P. Kumar, and R. Parshad, “Effect on antioxidant levels in patients of breast carcinoma during neoadjuvant chemotherapy and mastectomy,” Malaysian Journal of Medical Sciences, vol. 17, no. 2, pp. 24–28, 2010. View at Google Scholar · View at Scopus
  47. A. B. Prabasheela, A. K. Singh, A. Fathima, K. Pragulbh, N. J. Deka, and R. Kumar, “Association between antioxidant enzymes and breast cancer,” Recent Research in Science and Technology, vol. 3, no. 11, pp. 93–95, 2011. View at Google Scholar
  48. J. Kasapović, S. Pejić, V. Stojiljković et al., “Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide,” Clinical Biochemistry, vol. 43, no. 16-17, pp. 1287–1293, 2010. View at Publisher · View at Google Scholar
  49. C. P. Rajneesh, A. Manimaran, K. R. Sasikala, and P. Adaikappan, “Lipid peroxidation and antioxidant status in patients with breast cancer,” Singapore Medical Journal, vol. 49, no. 8, pp. 640–643, 2008. View at Google Scholar · View at Scopus
  50. M. Gago-Dominguez, J. E. Castelao, M. C. Pike, A. Sevanian, and R. W. Haile, “Role of lipid peroxidation in the epidemiology and prevention of breast cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 12, pp. 2829–2839, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. H. R. Hasan, T. H. Mathkor, and M. H. Al-Habal, “Superoxide dismutase isoenzyme activities in plasma and tissues of Iraqi patients with breast cancer,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 6, pp. 2571–2576, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Badid, F. Z. Baba Ahmed, H. Merzouk et al., “Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer,” Pathology and Oncology Research, vol. 16, no. 2, pp. 159–167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. R. K. Gupta, A. K. Patel, R. Kumari et al., “Interactions between oxidative stress, lipid profile and antioxidants in breast cancer: a Case Control Study,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 12, pp. 6295–6298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. M. J. Ramírez-Expósito, E. Sánchez-López, C. Cueto-Ureña et al., “Circulating oxidative stress parameters in pre- and post-menopausal healthy women and in women suffering from breast cancer treated or not with neoadjuvant chemotherapy,” Experimental Gerontology, vol. 58, pp. 34–42, 2014. View at Publisher · View at Google Scholar
  55. P. L. Olive and J. P. Banáth, “The comet assay: a method to measure DNA damage in individual cells,” Nature Protocols, vol. 1, no. 1, pp. 23–29, 2006. View at Publisher · View at Google Scholar
  56. P. Møller, “The alkaline Comet assay: towards validation in biomonitoring of DNA damaging exposures,” Basic & Clinical Pharmacology & Toxicology, vol. 98, no. 4, pp. 336–345, 2006. View at Publisher · View at Google Scholar
  57. C. M. Gedik, S. W. B. Ewen, and A. R. Collins, “Single-cell gel electrophoresis applied to the analysis of UV-C damage and its repair in human cells,” International Journal of Radiation Biology, vol. 62, no. 3, pp. 313–320, 1992. View at Publisher · View at Google Scholar · View at Scopus
  58. A. N. C. Sortibrán, M. G. O. Téllez, and R. R. Rodríguez-Arnaiz, “Genotoxic profile of inhibitors of topoisomerases I (camptothecin) and II (etoposide) in a mitotic recombination and sex-chromosome loss somatic eye assay of Drosophila melanogaster,” Mutation Research—Genetic Toxicology and Environmental Mutagenesis, vol. 604, no. 1-2, pp. 83–90, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. G. M. Zúñiga-González, O. Torres-Bugarín, A. L. Zamora-Perez et al., “Induction of micronucleated erythrocytes in mouse peripheral blood after cutaneous application of 5-fluorouracil,” Archives of Medical Research, vol. 34, no. 2, pp. 141–144, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Noordhuis, U. Holwerda, C. L. van der Wilt et al., “5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers,” Annals of Oncology, vol. 15, no. 7, pp. 1025–1032, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. L. P. Swift, A. Rephaeli, A. Nudelman, D. R. Phillips, and S. M. Cutts, “Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death,” Cancer Research, vol. 66, no. 9, pp. 4863–4871, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. N. Suhail, N. Bilal, H. Y. Khan et al., “Effect of vitamins C and e on antioxidant status of breast-cancer patients undergoing chemotherapy,” Journal of Clinical Pharmacy and Therapeutics, vol. 37, no. 1, pp. 22–26, 2012. View at Publisher · View at Google Scholar · View at Scopus